The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive

por Kast, Richard E.
Publicado 2023

Evidence that Amphotericin B Mediates Reactivation of Latent Epstein-Barr Virus in Hodgkin's Lymphoma Allowing Cytotoxicity by Acyclovir

por Kast, Richard E.
Publicado 2006

Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers

por Kast, Richard E.
Publicado 2015

The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir

por Kast, Richard E
Publicado 2015

Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

por Kast, Richard E.
Publicado 2018

Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment

por Kast, Richard E.
Publicado 2018

Research Supporting a Pilot Study of Metronomic Dapsone during Glioblastoma Chemoirradiation

por Kast, Richard E.
Publicado 2021

High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth—Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO Regimen

por Kast, Richard E.
Publicado 2022

Oxidizing to death: Disulfiram for cancer cell killing

por Brüning, Ansgar, Kast, Richard E
Publicado 2014

How influenza’s neuraminidase promotes virulence and creates localized lung mucosa immunodeficiency

por Bhatia, Ajay, Kast, Richard E.
Publicado 2006

Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)

por Altschuler, Eric L., Kast, Richard E.
Publicado 2020

Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct

por Söderlund, Johan, Erhardt, Sophie, Kast, Richard E
Publicado 2010

Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU

por Kanwar, Badar, Khattak, Asif, Kast, Richard E.
Publicado 2022

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs

por Kast, Richard E., Halatsch, Marc-Eric, Rosell, Rafael
Publicado 2021

CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous...

por Kast, Richard E., Karpel-Massler, Georg, Halatsch, Marc-Eric
Publicado 2014

Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition

por Papaioannou, Margarita, Mylonas, Ioannis, Kast, Richard E., Brüning, Ansgar
Publicado 2013

Benefits of Using Dapsone in Patients Hospitalized with COVID-19

por Kanwar, Badar A., Khattak, Asif, Balentine, Jenny, Lee, Jong Hoon, Kast, Richard E.
Publicado 2022

Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma

por Pala, Andrej, Karpel-Massler, Georg, Kast, Richard Eric, Wirtz, Christian Rainer, Halatsch, Marc-Eric
Publicado 2012

Involvement of MicroRNA in T-Cell Differentiation and Malignancy

por Saki, Najmaldin, Abroun, Saeid, Soleimani, Masoud, Hajizamani, Saeideh, Shahjahani, Mohammad, Kast, Richard E., Mortazavi, Yousef
Publicado 2015

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen

por Kast, Richard E, Skuli, Nicolas, Karpel-Massler, Georg, Frosina, Guido, Ryken, Timothy, Halatsch, Marc-Eric
Publicado 2017